TORONTO – Neupath Health Inc. and Cynergi Health Partners have signed a memorandum of understanding that could see Cynergi’s virtual reality (VR) software combined with Neupath’s remote pain management platform. The platform is expected to benefit from the therapeutic potential of Austin, Texas-based Cynergi’s Rilaxta VRx to lower patient anxiety and perception of pain as they walk through restful, VR-created landscapes. “We don’t see another group taking a similar, holistic approach to pain management that we are,” Neupath CEO Grant Connelly told BioWorld.